Epigenomics AG (EPGNF)
1.12
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Epigenomics Max Drawdown (5Y) : 96.46% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.46% |
| August 31, 2026 | 96.46% |
| July 31, 2026 | 96.46% |
| June 30, 2026 | 96.46% |
| May 31, 2026 | 96.46% |
| April 30, 2026 | 96.46% |
| March 31, 2026 | 96.46% |
| February 28, 2026 | 96.46% |
| January 31, 2026 | 96.46% |
| December 31, 2025 | 96.46% |
| November 30, 2025 | 96.46% |
| October 31, 2025 | 96.46% |
| September 30, 2025 | 96.46% |
| August 31, 2025 | 96.46% |
| July 31, 2025 | 96.46% |
| June 30, 2025 | 96.46% |
| May 31, 2025 | 96.46% |
| April 30, 2025 | 96.46% |
| March 31, 2025 | 96.46% |
| February 28, 2025 | 96.46% |
| January 31, 2025 | 96.46% |
| December 31, 2024 | 96.46% |
| November 30, 2024 | 96.46% |
| October 31, 2024 | 96.46% |
| September 30, 2024 | 96.46% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.46% |
| July 31, 2024 | 96.46% |
| June 30, 2024 | 96.46% |
| May 31, 2024 | 96.46% |
| April 30, 2024 | 96.46% |
| March 31, 2024 | 96.46% |
| February 29, 2024 | 96.46% |
| January 31, 2024 | 96.46% |
| December 31, 2023 | 96.46% |
| November 30, 2023 | 96.46% |
| October 31, 2023 | 96.46% |
| September 30, 2023 | 96.46% |
| August 31, 2023 | 96.46% |
| July 31, 2023 | 96.46% |
| June 30, 2023 | 96.46% |
| May 31, 2023 | 96.46% |
| April 30, 2023 | 96.46% |
| March 31, 2023 | 96.46% |
| February 28, 2023 | 96.46% |
| January 31, 2023 | 96.46% |
| December 31, 2022 | 96.46% |
| November 30, 2022 | 96.46% |
| October 31, 2022 | 96.27% |
| September 30, 2022 | 95.30% |
| August 31, 2022 | 95.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| CureVac NV | 98.30% |
| PAION AG | 100.00% |
| Anbio Biotechnology | -- |
| Anika Therapeutics, Inc. | 83.15% |
| Perspective Therapeutics, Inc. | 93.08% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 18.10 |
| Beta (5Y) | -2.691 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 256.7% |
| Historical Sharpe Ratio (5Y) | -0.0344 |
| Historical Sortino (5Y) | -0.1812 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.10% |